Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2-Reference-Cited by-同舟云学术

Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2

Published:2009-09 Issue:9 Volume:53 Page:3611-3619
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Ntemgwa Michel L.¹²,Toni Thomas d'Aquin¹,Brenner Bluma G.¹²,Camacho Ricardo J.³,Wainberg Mark A.¹²

Affiliation:

1. McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada

2. Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada

3. Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00154-09

Reference92 articles.

1. Adje-Toure, C. A., R. Cheingsong, J. G. Garcia-Lerma, S. Eholie, M. Y. Borget, J. M. Bouchez, R. A. Otten, C. Maurice, M. Sassan-Morokro, R. E. Ekpini, M. Nolan, T. Chorba, W. Heneine, and J. N. Nkengasong. 2003. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Cote d'Ivoire. AIDS17(Suppl. 3):S49-S54.

2. Andreasson, P. A., F. Dias, A. Naucler, S. Andersson, and G. Biberfeld. 1993. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS7:989-993.

3. TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1

4. Barre-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 2004. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. Rev. Invest Clin.56:126-129.

5. CCR5, GPR15, and CXCR6 Are Major Coreceptors of Human Immunodeficiency Virus Type 2 Variants Isolated from Individuals with and without Plasma Viremia

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing for human immunodeficiency virus;Diagnostic Molecular Pathology;2024

2. Antivirals and Vaccines;International Journal of Molecular Sciences;2023-06-19

3. Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds;International Journal of Molecular Sciences;2023-03-21

4. High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients;International Journal of Molecular Sciences;2022-11-18

5. Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era;AIDS;2021-07-06